NEW YORK (GenomeWeb News) — Clinical Data today said that affiliates of company chairman RJ Kirk exercised warrants for $3.7 million in shares.
 
The purchase for 190,505 shares of the company’s common stock, valued at $19.45 a share, came from warrants issued in June 2006, the company said.
 
Clinical Data President and CEO Drew Fromkin said the cash “strengthens the company’s balance sheet and provides additional liquidity” to support the third phase of clinical trials for Vilazodone, among other projects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.